Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$772K Buy
+2,800
New +$791K ﹤0.01% 3818
2021
Q4
Sell
-12,100
Closed -$2.42M 4341
2021
Q3
$2.42M Buy
+12,100
New +$2.63M 0.01% 1811
2021
Q2
Sell
-6,000
Closed -$1.45M 4097
2021
Q1
$1.45M Buy
+6,000
New +$1.34M ﹤0.01% 1976
2020
Q4
Sell
-5,600
Closed -$949K 3383
2020
Q3
$949K Buy
5,600
+1,400
+33% +$246K ﹤0.01% 1788
2020
Q2
$788K Sell
4,200
-300
-7% -$56.9K ﹤0.01% 1689
2020
Q1
$797K Sell
4,500
-6,000
-57% -$1.16M 0.01% 1594
2019
Q4
$2.15M Sell
10,500
-3,200
-23% -$587K 0.01% 1530
2019
Q3
$2.08M Sell
13,700
-42,400
-76% -$6.9M 0.01% 1408
2019
Q2
$8.84M Buy
+56,100
New +$8.79M 0.03% 643
2018
Q4
Sell
-7,400
Closed -$1.54M 3033
2018
Q3
$1.54M Buy
7,400
+4,400
+147% +$816K ﹤0.01% 1664
2018
Q2
$510K Buy
+3,000
New +$519K ﹤0.01% 2634

Other funds holding CI

John Overdeck's CI Position: Q2 2026 in Review

John Overdeck increased its Cigna (CI) stake by 183% in Q2 2026, buying an estimated $331M and bringing the position to 1,813,110 shares worth $500M. The position accounts for 0.36% of the portfolio, ranked #46.

John Overdeck first reported a position in CI in Q4 2013 and has held it in 39 quarters since. 1,690 funds tracked by Wall St. Rank hold CI as of Q2 2026.

  • John Overdeck held 1,813,110 shares of Cigna worth $500M as of Q2 2026.
  • John Overdeck bought 1,171,762 Cigna shares in Q2 2026, an estimated $331M.
  • Cigna made up 0.36% of John Overdeck's portfolio in Q2 2026, its #46 holding.
  • John Overdeck first reported a position in Cigna in Q4 2013 and has held it in 39 quarters since.
  • 1,690 funds tracked by Wall St. Rank held Cigna as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.